Ajinomoto Co., Inc. introduces a unique solution for early detection of ketosis and other peripartum diseases

Preventative testing with AjiPro-Health identifies disease before causing economic impact for dairy producers

Ajinomoto Co., Inc. will be exhibiting at the World Dairy Expo in October to introduce its new solution, AjiPro-Health.

Ajinomoto Co., Inc. is introducing its proprietary blood test, AjiPro-Health, for early detecting of peripartum diseases in dairy cows. In a time when dairy producers are facing multiple challenges, the health management solution helps them tackle herd health with a new tool to prevent economic impacts caused by ketosis and other peripartum diseases. It’s a simple, low-cost analysis of amino acids to indicate disease risks up to 21 days before calving, whereas dairy producers often do not spot disease until the onset after calving. Identifying disease potential early with AjiPro-Health is supposed to prevent the disease ratio on farms by 80% and increase production by 2.7 pounds per day on average.

Early treatment of high-risk cows also improves breed-back rates by reducing the number of days open by an average of 16 days. Balancing dietary Lysine levels during the close-up period has been confirmed to decrease peripartum diseases. Ajinomoto Co., Inc. also offers AjiPro^®-L, the number one Lysin product in the U.S.

Ajinomoto Co., Inc.’s solution and treatment, listed in the World Dairy Expo’s Innovation Unveiled roundup of new products on the market, allows producers to keep their herds healthy and prevent disease while staying competitive and profitable. Ajinomoto Co., Inc. is excited to share information about their new solution with U.S. dairy producers.

See Us At:

Booth TC 453

World Dairy Expo

Alliant Energy Center

Madison, Wisconsin